Search alternatives:
point decrease » point increase (Expand Search)
mg decrease » nn decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
50 point » 5 point (Expand Search), _ point (Expand Search), a point (Expand Search)
50 mg » 10 mg (Expand Search)
point decrease » point increase (Expand Search)
mg decrease » nn decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
50 point » 5 point (Expand Search), _ point (Expand Search), a point (Expand Search)
50 mg » 10 mg (Expand Search)
-
1
-
2
-
3
Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.
Published 2016“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Decreased oscillatory flow decreases <i>klf2a</i> expression.
Published 2009“…<p>(A) RFF is decreased by alterations in heart rate. …”
-
12
Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50.
Published 2024“…Relative band densities from three independent experiments were analyzed. (A) OxLDL decreased co-immunoprecipitation of IκBα with both RelA and p50, and olaparib reversed the effect of oxLDL on the dissociation of IκBα with RelA and p50. …”
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20